Kinetics of phenobarbital in normal subjects and epileptic patients |
| |
Authors: | A. J. Wilensky P. N. Friel R. H. Levy C. P. Comfort S. P. Kaluzny |
| |
Affiliation: | (1) Regional Epilepsy Center, Department of Neurological Surgery, School of Medicine, University of Washington, Seattle, USA;(2) Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, USA |
| |
Abstract: | Summary The kinetics of phenobarbital (PB) were evaluated in six normal subjects and six epileptic patients treated with phenytoin or carbamazepine. Each normal subject received three single doses of PB: PB-sodium 130 mg i.v. (IV), PB sodium 130 mg i.m. (IM), and PB acid 100 mg orally (PO), in random order at least one month apart. After IV PB distributive half-lives varied from 0.13 to 0.70 h, disposition half-lives were 75 to 126 h, steady state volume of distribution (Vss) was 0.54±0.03 l/kg, and clearance (CL) was 3.8±0.77 ml/h/kg. Absolute bioavailability of IM PB was 101±13%, of PO PB (corrected for dose) 100±11%. Peak serum PB concentrations were achieved from 2 to 8 h after IM administration, and from 0.5 to 4 h after PO administration. Epileptic patients exhibited similar PB kinetics: disposition half-lives were 77 to 128 h, Vss 0.61±0.05 l/kg, and Cl 3.9±0.76 ml/h/kg. Phenobarbital appears to represent an exception among antiepileptic drugs, in that pharmacokinetic data obtained in normals can reasonably be extrapolated to the epileptic population. |
| |
Keywords: | phenobarbital epilepsy kinetics bioavailability epileptic patients |
本文献已被 SpringerLink 等数据库收录! |
|